India’s leading dialysis chain, NephroPlus, obtained SEBI approval for its ₹353 crore initial public offering aimed at scaling its healthcare infrastructure and technology-enabled renal care. The IPO will comprise a fresh issue and offer-for-sale by existing investors. The proceeds are expected to finance the establishment of new centers and digital patient-monitoring systems. NephroPlus currently operates over 320 dialysis centers in 190 cities. Its planned listing underscores investor appetite for healthcare growth stories driven by rising demand for chronic disease management services in India’s expanding medical ecosystem.